Agios Pharmaceuticals, Inc., the leading biopharmaceutical company focused on discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases, today announced that David Schenkein, M.D., chief executive officer, is scheduled to present at the Cowen and Company 33rd Annual Health Care Conference on Monday, March 4, 2013 at 9:30AM EST at the Boston Marriott Copley Place.
